Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03610997 · ClinicalTrials.gov registry record · NA
Photorefractive Keratectomy for Severe Anisometropia and Isoametropia Associated With Amblyopia
A NA study, sponsored by Baylor College of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT03610997 is a NA study that was terminated before completion, run by Baylor College of Medicine. The registered enrollment target is 200 participants.
The verdict
NCT03610997, a NA study, was terminated before completion, sponsored by Baylor College of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
Photorefractive keratectomy (PRK) with excimer laser has been used successfully to treat myopia, hyperopia, and astigmatism in adults for over 35 years. Children with high refractive errors that go untreated will develop severe amblyopia. PRK can normalize high refractive errors and potentially improve the visual acuity in affected children. The purpose of this study is to investigate whether children with high anisometropia or isoametropia with amblyopia that are nonresponsive to standard therapy and receive PRK develop better longterm visual acuity.
Interventions
- PROCEDURE Photorefractive keratectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2001-01-01 |
| Est. Completion | 2024-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03610997
The ClinicalTrials.gov registry entry for NCT03610997 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor College of Medicine, which has 616 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Photorefractive keratectomy is the first listed.
NCT03610997 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03610997 about?
NCT03610997 is a clinical study titled "Photorefractive Keratectomy for Severe Anisometropia and Isoametropia Associated With Amblyopia". Photorefractive keratectomy (PRK) with excimer laser has been used successfully to treat myopia, hyperopia, and astigmatism in adults for over 35 years. Children with high refractive errors that go untreated will develop severe amblyopia. PRK can normalize high refractive errors and potentially impr...
What is the current status of trial NCT03610997?
This trial is currently terminated. It is a NA study. The enrollment target is 200 participants. The study started on 2001-01-01. Estimated completion is 2024-09-01.
What interventions are being tested in trial NCT03610997?
The interventions under investigation include: Photorefractive keratectomy (PROCEDURE).
Who is sponsoring clinical trial NCT03610997?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.